ImmunOs Therapeutics Appoints Claudia Berger as SVP Clinical Development
ImmunOs Therapeutics AG, a Swiss biotechnology company developing a new class of biologics for the treatment of cancer a…
ImmunOs Therapeutics AG, a Swiss biotechnology company developing a new class of biologics for the treatment of cancer a…
Mindpeak’s CTO Dr. Tobias Lang and Dr. med. Holger Hauspurg from the Institut for Hematopathology Hamburg describe the f…
More than ten million people worldwide suffer from decompensated cirrhosis, often as a result of severe alcoholic hepati…
"Despite all the adversities, which like most other companies we have been faced with in 2020, we look back with pride o…
The principles underlying psychoanalytic technique and their impact on practice are the main objects of this comprehensi…
At the 3rd Wetzlar Medical Symposium about MBST magnetic resonance therapy in Wetzlar, Dr. med. Maren Van de Perck was h…
At the 3rd Wetzlar Medical Symposium about MBST magnetic resonance therapy in Wetzlar, the specialist for orthopaedics,…
In times of increased infection risk - as during the current corona pandemic with SARS-CoV-2 - the skin is stressed by f…
On Rare Disease Day, February 29th, the International Osteoporosis Foundation (IOF) calls on governments and healthcare…
. - Christina Triantafyllou, Ph.D., was nominated for the award along with Professor Arnd Dörfler, M.D., Head of Univers…